Core Scientific, Inc./txCORZEarnings & Financial Report
Nasdaq
NextMar 30, 2026
CORZ Q3 2025 Key Financial Metrics
Revenue
$81.1M
Gross Profit
$3.9M
Operating Profit
$-57.4M
Net Profit
$-146.7M
Gross Margin
4.8%
Operating Margin
-70.8%
Net Margin
-180.8%
YoY Growth
-14.9%
EPS
$-0.46
Financial Flow
Core Scientific, Inc./tx Q3 2025 Financial Summary
Core Scientific, Inc./tx reported revenue of $81.1M for Q3 2025, with a net profit of $-146.7M (-180.8% margin). Cost of goods sold was $77.2M, operating expenses totaled $61.3M.
Key Financial Metrics
| Total Revenue | $81.1M |
|---|---|
| Net Profit | $-146.7M |
| Gross Margin | 4.8% |
| Operating Margin | -70.8% |
| Report Period | Q3 2025 |
Core Scientific, Inc./tx Annual Revenue by Year
Core Scientific, Inc./tx annual revenue history includes year-by-year totals (for example, 2024 revenue was $510.7M).
| Year | Annual Revenue |
|---|---|
| 2024 | $510.7M |
| 2023 | $502.4M |
| 2022 | $640.3M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $141.9M | $179.3M | $141.1M | $95.4M | $94.9M | $79.5M | $78.6M | $81.1M |
| YoY Growth | 17.1% | 48.6% | 11.2% | -15.5% | -33.1% | -55.6% | -44.3% | -14.9% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $712.2M | $814.0M | $761.5M | $921.9M | $1.60B | $1.63B | $1.98B | $2.30B |
| Liabilities | $1.31B | $1.13B | $1.85B | $1.65B | $2.42B | $1.81B | $3.04B | $3.42B |
| Equity | $-596.9M | $-318.5M | $-1.08B | $-729.4M | $-820.2M | $-181.5M | $-1.06B | $-1.13B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $21.7M | $22.2M | $1.2M | $5.7M | $13.8M | $-40.6M | $34.0M | $131.8M |